ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Eisai starts Phase III clinical trial for Alzheimer's drug
March 25, 2019Clarity AD is a global placebo-controlled, double-blind, parallel-group…… -
Bio-Thera Solutions Announces Initiation of Phase III Clinical Trial for BAT1806, a Proposed Biosimilar of Actemra
January 23, 2019Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun in a Phase III clinical study for its tocilizumab biosimilar, BAT1806. Bio-Thera's Phase III clinical trial will compare the safety and efficacy of BAT1806
Pharma Sources Insight January 2025
